71.25
-1.09 (-1.51%)
-1.09 (-1.51%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Novo Nordisk | NVO | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -1.09 | -1.51% | 71.25 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 72.16 | 71.01 | 72.24 | 71.25 | 72.34 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 10,121 | 873,193 | $ 71.44 | $ 62,376,678 | 1,059,584 | 49.24 - 75.8601 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:00:00 | 24,599 | $ 71.25 | USD |
Novo Nordisk Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 164.68B | 2.31B | 2.31B | $ 19.92B | $ 6.90B | 2.46 | 26.50 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 1.24 | 1.74% | - | - |
Novo Nordisk News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NVO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 74.31 | 74.58 | 71.01 | 72.79 | 1,068,384 | -3.06 | -4.12% |
| 1 Month | 69.92 | 75.8601 | 68.98 | 72.90 | 1,271,707 | 1.33 | 1.9% |
| 3 Months | 67.77 | 75.8601 | 67.64 | 71.71 | 1,084,513 | 3.48 | 5.14% |
| 6 Months | 66.54 | 75.8601 | 63.22 | 69.85 | 1,076,351 | 4.71 | 7.08% |
| 1 Year | 61.04 | 75.8601 | 49.24 | 64.54 | 1,423,024 | 10.21 | 16.73% |
| 3 Years | 53.98 | 75.8601 | 41.229 | 54.92 | 1,434,122 | 17.27 | 31.99% |
| 5 Years | 52.20 | 75.8601 | 30.89 | 49.06 | 1,733,765 | 19.05 | 36.49% |
Novo Nordisk Description
| With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 20% of revenue) that specializes in protein therapies for hemophilia and other disorders. |
